Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
86.53
+1.84 (+2.18%)
Streaming Delayed Price
Updated: 3:14 PM EDT, Sep 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
50
51
Next >
10 Worst Performing Large-Caps Last 12 Months
↗
March 27, 2025
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.
Via
Talk Markets
Topics
Stocks / Equities
The Future of Healthcare: 10 Predictions For The Next Decade
March 27, 2025
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we...
Via
MarketMinute
Topics
Artificial Intelligence
Dexcom Appoints Jon Coleman as Chief Commercial Officer
March 25, 2025
From
DexCom, Inc.
Via
Business Wire
Tuesday's session: top gainers and losers in the S&P500 index
↗
March 25, 2025
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
Via
Chartmill
Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase.
↗
March 24, 2025
Based on a technical and fundamental analysis of NASDAQ:DXCM we ask: Is DEXCOM INC (NASDAQ:DXCM) on the Verge of a Major Breakout as a Strong Growth Stock?
Via
Chartmill
DexCom (DXCM): 3 Reasons We Love This Stock
March 24, 2025
Over the past six months, DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up might have investors contemplating their next...
Via
StockStory
Topics
Stocks
Is DexCom Gaining or Losing Market Support?
↗
March 21, 2025
Via
Benzinga
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers
March 21, 2025
Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.
Via
StockStory
Topics
Artificial Intelligence
Exploring the top movers within the S&P500 index during today's session.
↗
March 20, 2025
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
Via
Chartmill
Top S&P500 movers in Thursday's session
↗
March 20, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next
↗
March 19, 2025
Via
The Motley Fool
Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care
March 19, 2025
From
DexCom, Inc.
Via
Business Wire
10 Worst Performing Large-Caps Last 12 Months
↗
March 13, 2025
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.
Via
Talk Markets
Topics
Stocks / Equities
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
March 11, 2025
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest...
Via
StockStory
Topics
Artificial Intelligence
Which S&P500 stocks are moving on Monday?
↗
March 10, 2025
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
Via
Chartmill
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried
↗
March 10, 2025
The company is facing a regulatory setback. But one analyst doesn't expect that to impact its upcoming, potential approval.
Via
Investor's Business Daily
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
↗
March 10, 2025
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.
Via
Chartmill
Dexcom Appoints Renée Galá to Board of Directors
March 10, 2025
From
DexCom, Inc.
Via
Business Wire
DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
↗
March 03, 2025
Based on technical and fundamental analysis of NASDAQ:DXCM we find: DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.
Via
Chartmill
3 Growth Stocks to Buy and Hold Forever
↗
March 01, 2025
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
February 27, 2025
Via
Benzinga
Dexcom Announces Upcoming Conference Presentation
February 27, 2025
From
DexCom, Inc.
Via
Business Wire
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
February 27, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom...
Via
StockStory
Topics
Artificial Intelligence
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
↗
February 26, 2025
Via
The Motley Fool
These S&P500 stocks are moving in today's pre-market session
↗
February 19, 2025
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Via
Chartmill
Insulet Earnings: What To Look For From PODD
February 19, 2025
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect.
Via
StockStory
iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect
February 19, 2025
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.
Via
StockStory
What's going on in today's session: S&P500 movers
↗
February 14, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Via
Chartmill
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
↗
February 14, 2025
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential.
Via
Benzinga
In today's session, there are S&P500 stocks with remarkable trading volume.
↗
February 14, 2025
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via
Chartmill
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
50
51
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit